I can't imagine the financing will be non-dilutive, I give it a 10% shot at best, but such is life in developmental biotech, so I accept that, albeit grudgingly.

As for today, you may have hit the nail on the head with new ARNA money listening in the presentation, and certainly some of the rise over the last few weeks had some ARNA flavor to it, too. But I think it was mainly that tout service. If you go back and look at the volume which has been heavy during the runup, it coincides very well with the touts call.

I mean, the story of MNKD is compelling, especially when hearing it for the first couple of times!